Avondale Wealth Management’s GoodRx Holdings GDRX Stock Holding History

Avondale Wealth Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,500	Closed	-$46.9K	–	128
2023 Q1	$46.9K	Buy	7,500 +7,005	+1,415%	+$39.1K	0.04%	80
2022 Q4	$2.31K	Hold	495	–	–	﹤0.01%	115
2022 Q3	$2K	Hold	495	–	–	﹤0.01%	113
2022 Q2	$3K	Hold	495	–	–	﹤0.01%	103
2022 Q1	$10K	Sell	495 -500	-50%	-$11.5K	0.01%	99
2021 Q4	$33K	Sell	995 -2,116	-68%	-$85.1K	0.03%	76
2021 Q3	$128K	Hold	3,111	–	–	0.13%	53
2021 Q2	$112K	Sell	3,111 -3,000	-49%	-$111K	0.1%	58
2021 Q1	$238K	Buy	6,111 +4,488	+277%	+$202K	0.23%	37
2020 Q4	$65K	Buy	1,623 +1,344	+482%	+$61.7K	0.08%	43
2020 Q3	$16K	Buy	+279	New	+$14.8K	0.02%	80

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Avondale Wealth Management's GDRX Position: Q2 2023 in Review

Avondale Wealth Management sold out of GoodRx Holdings (GDRX) in Q2 2023, closing a stake of 7,500 shares — an estimated $46.9K sold.

Avondale Wealth Management first reported a position in GDRX in Q3 2020 and held it in 11 quarters. The position peaked at $238K in Q1 2021. 147 funds tracked by Wall St. Rank hold GDRX as of Q2 2023.

Avondale Wealth Management reported no remaining GoodRx Holdings position as of Q2 2023 after selling out during the quarter.
Avondale Wealth Management sold 7,500 GoodRx Holdings shares in Q2 2023, an estimated $46.9K.
Avondale Wealth Management first reported a position in GoodRx Holdings in Q3 2020 and held it in 11 quarters.
Avondale Wealth Management's GoodRx Holdings position peaked at $238K in Q1 2021.
147 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2023.

Based on Avondale Wealth Management's 13F filing for Q2 2023, filed 6 Jul 2023.